Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Microbial and immune faecal determinants in infants hospitalized with COVID-19 reflect bifidobacterial dysbiosis and immature intestinal immunity.
Gutiérrez-Díaz I, Sanz-Martinez M, Castro AM, Rodríguez-Belvís MV, Carreira N, Jiménez S, Mangas C, Queralt M, Herrador M, Martín-Masot R, Ferrer P, Navas-López VM, Espín B, Leis R, Díaz JJ, Delgado S. Gutiérrez-Díaz I, et al. Among authors: navas lopez vm. Eur J Pediatr. 2023 Oct;182(10):4633-4645. doi: 10.1007/s00431-023-05140-8. Epub 2023 Aug 9. Eur J Pediatr. 2023. PMID: 37555973 Free PMC article.
Herbst's Triad as a Manifestation of Gastroesophageal Reflux Disease.
Torcuato Rubio E, Martín-Masot R, Ortiz Pérez P, Serrano Nieto MJ, Díaz Ruiz J, Blasco-Alonso J, Navas-López VM. Torcuato Rubio E, et al. JPGN Rep. 2021 Mar 30;2(2):e066. doi: 10.1097/PG9.0000000000000066. eCollection 2021 May. JPGN Rep. 2021. PMID: 37207055 Free PMC article. No abstract available.
Assessment of the length of sick leave in patients with inflammatory bowel disease.
Ramos Cózar SN, Masot RM, Gallego BR, Rubio L, Cabanillas Moruno JL, Navas López VM. Ramos Cózar SN, et al. Among authors: navas lopez vm. Gastroenterol Hepatol. 2024 May 5:502194. doi: 10.1016/j.gastrohep.2024.502194. Online ahead of print. Gastroenterol Hepatol. 2024. PMID: 38714272 English, Spanish.
STEP-CD study: ustekinumab use in paediatric Crohn's disease-a multicentre retrospective study from paediatric IBD Porto group of ESPGHAN.
Pujol-Muncunill G, Navas-López VM, Ledder O, Cohen S, Lekar M, Turner D, Kolho KL, Levine A, Croft NM, Bronsky J, Shouval DS, Assa A, Harris R, Kiparissi F, Aloi M, Afzal NA, Tzivinikos C, Barrio J, Norden C, Vega MJB, Buderus S, de Valderrama AF, de Ridder L, García-Romero R, Medina E, Sánchez C, Velasco M, Vicente S, Wilson DC, Naik S, Hradsky O, Cococcioni L, Martin-de-Carpi J. Pujol-Muncunill G, et al. Among authors: navas lopez vm. Eur J Pediatr. 2024 May 3. doi: 10.1007/s00431-024-05588-2. Online ahead of print. Eur J Pediatr. 2024. PMID: 38700692
Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment.
Salvador-Martín S, Rubbini G, Vellosillo P, Zapata-Cobo P, Velasco M, Palomino LM, Clemente S, Segarra O, Moreno-Álvarez A, Fernández-Lorenzo A, Pérez-Moneo B, Montraveta M, Sánchez C, Tolín M, Loverdos I, Fobelo MJ, Navas-López VM, Magallares L, García-Romero R, Torres-Peral R, Rodríguez A, Bossacoma F, Merino-Bohórquez V, Salcedo E, Álvarez R, Dopazo A, Sanjurjo-Sáez M, López-Fernández LA. Salvador-Martín S, et al. Among authors: navas lopez vm. Biomed Pharmacother. 2024 Apr;173:116299. doi: 10.1016/j.biopha.2024.116299. Epub 2024 Feb 23. Biomed Pharmacother. 2024. PMID: 38401525 Free article.
Mitochondrial Stress Links Environmental Triggers with Pro-Inflammatory Signaling in Crohn's Disease.
Martín-Reyes F, Bernal M, Rodríguez-Díaz C, Rodríguez-de Los Reyes D, Ho-Plagaro A, Rodríguez-Pacheco F, Camacho-Martel L, Camargo-Camero R, Rodríguez-González FJ, Alcain-Martínez G, Martín-Masot R, Navas-López VM, Villanueva-Paz M, Lucena MI, García-Fuentes E, López-Gómez C. Martín-Reyes F, et al. Among authors: navas lopez vm. Antioxidants (Basel). 2023 Dec 13;12(12):2105. doi: 10.3390/antiox12122105. Antioxidants (Basel). 2023. PMID: 38136224 Free PMC article.
Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.
Zapata-Cobo P, Salvador-Matín S, Velasco M, Palomino LM, Clemente S, Segarra O, Moreno-Álvarez A, Fernández-Lorenzo A, Pérez-Moneo B, Montraveta M, Sánchez C, Tolín M, Loverdos I, Fobelo MJ, Navas-López VM, Magallares L, García-Romero R, Sánchez-Hernández JG, Rodríguez A, Bossacoma F, Balboa MJ, Salcedo E, Sanjurjo-Sáez M, López-Fernández LA. Zapata-Cobo P, et al. Among authors: navas lopez vm. Pharmacol Res. 2023 Oct;196:106938. doi: 10.1016/j.phrs.2023.106938. Epub 2023 Sep 23. Pharmacol Res. 2023. PMID: 37748560 Free article. No abstract available.
111 results